These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15562293)

  • 41. Prenatal stress induces vulnerability to nicotine addiction and alters D2 receptors' expression in the nucleus accumbens in adult rats.
    Said N; Lakehayli S; El Khachibi M; El Ouahli M; Nadifi S; Hakkou F; Tazi A
    Neuroscience; 2015 Sep; 304():279-85. PubMed ID: 26192093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization.
    Wooters TE; Neugebauer NM; Rush CR; Bardo MT
    Neuropsychopharmacology; 2008 Apr; 33(5):1137-48. PubMed ID: 17581534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of dopamine D3 receptor in alleviating behavioural deficits in animal models of post-traumatic stress disorder.
    Song D; Ge Y; Chen Z; Shang C; Guo Y; Zhao T; Li Y; Wu N; Song R; Li J
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):190-200. PubMed ID: 29510167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of dopamine D3 receptors in thermoregulation: a reappraisal.
    Perachon S; Betancur C; Pilon C; Rostène W; Schwartz JC; Sokoloff P
    Neuroreport; 2000 Jan; 11(1):221-5. PubMed ID: 10683862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opiate exposure state controls dopamine D3 receptor and cdk5/calcineurin signaling in the basolateral amygdala during reward and withdrawal aversion memory formation.
    Rosen LG; Rushlow WJ; Laviolette SR
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):59-66. PubMed ID: 28627448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits.
    Carnicella S; Drui G; Boulet S; Carcenac C; Favier M; Duran T; Savasta M
    Transl Psychiatry; 2014 Jun; 4(6):e401. PubMed ID: 24937095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice.
    Wang J; Jia Y; Li G; Wang B; Zhou T; Zhu L; Chen T; Chen Y
    Int J Neuropsychopharmacol; 2018 May; 21(5):448-460. PubMed ID: 29390063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nicotine modulation of adolescent dopamine receptor signaling and hypothalamic peptide response.
    Mojica CY; Dao JM; Yuan M; Loughlin SE; Leslie FM
    Neuropharmacology; 2014 Feb; 77():285-93. PubMed ID: 24157491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.
    Le Foll B; Goldberg SR
    Neuroreport; 2004 Sep; 15(13):2139-43. PubMed ID: 15486497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward.
    Sagheddu C; Scherma M; Congiu M; Fadda P; Carta G; Banni S; Wood JT; Makriyannis A; Malamas MS; Pistis M
    Neuropharmacology; 2019 Jan; 144():327-336. PubMed ID: 30439418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats.
    Terry P; Katz JL
    Psychopharmacology (Berl); 1997 Nov; 134(2):201-12. PubMed ID: 9399385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.
    Kumar V; Bonifazi A; Ellenberger MP; Keck TM; Pommier E; Rais R; Slusher BS; Gardner E; You ZB; Xi ZX; Newman AH
    J Med Chem; 2016 Aug; 59(16):7634-50. PubMed ID: 27508895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine D(3) receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice.
    Song R; Zhang HY; Peng XQ; Su RB; Yang RF; Li J; Xi ZX; Gardner EL
    Neuropharmacology; 2013 Sep; 72():82-7. PubMed ID: 23643749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats.
    Bruijnzeel AW; Markou A
    Synapse; 2003 Oct; 50(1):20-8. PubMed ID: 12872290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).
    Brown RW; Kirby SL; Denton AR; Dose JM; Cummins ED; Drew Gill W; Burgess KC
    Schizophr Res; 2018 Apr; 194():107-114. PubMed ID: 28314679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice.
    Lv Y; Hu RR; Jing M; Zhao TY; Wu N; Song R; Li J; Hu G
    Acta Pharmacol Sin; 2019 May; 40(5):583-588. PubMed ID: 30224637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model.
    Duric V; Banasr M; Franklin T; Lepack A; Adham N; Kiss B; Gyertyán I; Duman RS
    Int J Neuropsychopharmacol; 2017 Oct; 20(10):788-796. PubMed ID: 28531264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist.
    Pilla M; Perachon S; Sautel F; Garrido F; Mann A; Wermuth CG; Schwartz JC; Everitt BJ; Sokoloff P
    Nature; 1999 Jul; 400(6742):371-5. PubMed ID: 10432116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine receptor D3 deficiency results in chronic depression and anxiety.
    Moraga-Amaro R; Gonzalez H; Pacheco R; Stehberg J
    Behav Brain Res; 2014 Nov; 274():186-93. PubMed ID: 25110304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diminished conditioned responding to the nicotine stimulus by antidepressant drugs with differing specificity for the serotonin and norepinephrine transporter.
    Dion AM; Sanderson SC; Murrin LC; Bevins RA
    Pharmacol Biochem Behav; 2012 Jan; 100(3):419-24. PubMed ID: 22005597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.